Antiviral Effects of Artesunate on Polyomavirus BK Replication in Primary Human Kidney Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral Effects of Artesunate on Polyomavirus BK Replication in Primary Human Kidney Cells
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 1, Pages 279-289
Publisher
American Society for Microbiology
Online
2013-10-22
DOI
10.1128/aac.01800-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child
- (2013) Nina Hakacova et al. JOURNAL OF CLINICAL VIROLOGY
- Large T Antigens of Polyomaviruses: Amazing Molecular Machines
- (2012) Ping An et al. Annual Review of Microbiology
- Artesunate induces G0/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells
- (2012) Zhongyong Jiang et al. ANTI-CANCER DRUGS
- Evidence for clinical activity of artesunate in multidrug-resistant herpes simplex infection following HSCT
- (2012) R S Sellar et al. BONE MARROW TRANSPLANTATION
- Leflunomide Efficacy and Pharmacodynamics for the Treatment of BK Viral Infection
- (2012) J. C. Krisl et al. Clinical Journal of the American Society of Nephrology
- Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: Phase 1b study
- (2012) Robert Miller et al. MALARIA JOURNAL
- Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle
- (2012) Sara Finaurini et al. TOXICOLOGY
- Roles of ATM and ATR-Mediated DNA Damage Responses during Lytic BK Polyomavirus Infection
- (2012) Mengxi Jiang et al. PLoS Pathogens
- The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants
- (2011) Sunwen Chou et al. ANTIVIRAL RESEARCH
- Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells
- (2011) Biswa Nath Sharma et al. ANTIVIRAL RESEARCH
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation
- (2011) Dana G. Wolf et al. ANTIVIRAL RESEARCH
- A reporter system for Epstein-Barr virus (EBV) lytic replication: Anti-EBV activity of the broad anti-herpesviral drug artesunate
- (2011) Sabrina Auerochs et al. JOURNAL OF VIROLOGICAL METHODS
- Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo
- (2011) Qiang Xu et al. Journal of Zhejiang University-SCIENCE B
- Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
- (2011) Carrie A Morris et al. MALARIA JOURNAL
- Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial
- (2011) Delia Bethell et al. PLoS One
- 1-O-Hexadecyloxypropyl Cidofovir (CMX001) Effectively Inhibits Polyomavirus BK Replication in Primary Human Renal Tubular Epithelial Cells
- (2010) C. H. Rinaldo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells
- (2010) Nathalie Schnepf et al. ANTIVIRAL RESEARCH
- Artesunate is Ineffective in Controlling Valganciclovir-Resistant Cytomegalovirus Infection
- (2010) P. Kar Han Lau et al. CLINICAL INFECTIOUS DISEASES
- Toxicity of the antimalarial artemisinin and its dervatives
- (2010) Thomas Efferth et al. CRITICAL REVIEWS IN TOXICOLOGY
- Conformational Rearrangements of SV40 Large T Antigen during Early Replication Events
- (2010) Isabel Cuesta et al. JOURNAL OF MOLECULAR BIOLOGY
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
- (2010) Arjen M Dondorp et al. LANCET
- Treatment of Polyomavirus Infection in Kidney Transplant Recipients: A Systematic Review
- (2010) Olwyn Johnston et al. TRANSPLANTATION
- BK Virus in Solid Organ Transplant Recipients
- (2009) H. H. Hirsch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pharmacokinetic Profiles of Artesunate After Single Intravenous Doses at 0.5, 1, 2, 4, and 8 mg/kg in Healthy Volunteers: A Phase I Study
- (2009) Qigui Li et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFκB p65
- (2009) Shihui Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate
- (2009) Jens Milbradt et al. JOURNAL OF CLINICAL VIROLOGY
- Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients
- (2009) Gunn-Hege Olsen et al. JOURNAL OF MEDICAL VIROLOGY
- Leflunomide Inhibition of BK Virus Replication in Renal Tubular Epithelial Cells
- (2009) E. Bernhoff et al. JOURNAL OF VIROLOGY
- Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression
- (2008) E. Bernhoff et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Polyomavirus BK Replication DynamicsIn VivoandIn Silicoto Predict Cytopathology and Viral Clearance in Kidney Transplants
- (2008) G. A. Funk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
- (2008) Michael Y. Shapira et al. CLINICAL INFECTIOUS DISEASES
- The Antiviral Activities of Artemisinin and Artesunate
- (2008) Thomas Efferth et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started